Marca Nominativa depositada no INPI em 30/11/2023 por RHEACELL GmbH & Co. KG, processo nº 501718654, nas classes 01, 05, 42, 44. Registro em vigor até 07/12/2032.
| Número do processo | 501718654 |
|---|---|
| Situação | Registro de marca em vigor (Madri) |
| Apresentação | Nominativa |
| Natureza | Madri Produto/Serviço |
| Data do depósito | 30/11/2023 |
| Data da concessão | 15/07/2025 |
| Vigência até | 07/12/2032 |
| Titular | RHEACELL GmbH & Co. KG |
| CNPJ/CPF do titular | — |
| UF · País | — · DE |
Stem cells for scientific use; stem cells for research use; cell growth media for growing cells for scientific use; stem cells for aesthetic purposes.;
Drugs for medical purposes; pharmaceutical and veterinary preparations; diagnostic agents; pharmaceutical preparations; preparations for medical purposes; preparations for biomedical purposes; pharmaceutical cell preparations for medical use; substances for medical use; substances for biomedical purposes; live implants for pharmaceutical purposes; biochemical and chemical products for medical use; biochemical and chemical products for pharmaceutical purposes; biochemical and chemical products for diagnostic purposes; proteins for medical purposes; biological preparations for medical and veterinary purposes, and pharmaceutical and veterinary preparations, all for external and systemic use; biological, pharmaceutical and veterinary preparations for skin care for medical purposes; medical dressings; preparations for wound treating and healing; biological, pharmaceutical and veterinary preparations for the treatment of chronic wounds, ulcers, burns and surgical wounds; stem cells for medical purposes; stem cells for veterinary purposes; somatic stem cell therapeutics; fibroblasts for medical purposes; fibroblasts for surgical beauty purposes; pharmaceutical implants; surgical implants derived from stem cells; surgical implants derived from fibroblasts; biological tissue for implantation; growth media for culturing cells for medical purposes; pharmaceutical preparations for tissue regeneration; vascular grafts; living tissue; biotechnologically engineered tissue products.;
Pharmaceutical drug development; scientific and technological services; research and development services in the fields of cell diagnostics and cell therapy and surgical and medical instruments; industrial analysis and research services; scientific research for medical purposes; stem cell research; scientific and medical research and development; scientific research, testing and analysis services; medical research; biomedical research; research and development in the field of biotechnology; research and development in the field of gene therapy; research and development in the field of immunology; research and development in the field of antibodies; research and development in the field of antibody technology; research and development in the field of bacteriology; research and development in the field of gene expression systems; research and development in the field of vaccines; development of industrial processes; industrial process research; research and development services for the pharmaceutical industry; research and development of new products for others; consultancy in the field of pharmaceutical research; providing information about medical and scientific research for pharmaceutical products; preparation of reports relating to scientific research.;
Medical services; medical diagnostic services [carrying out tests and analyses]; medical assistance; clinic services; hospital services; plastic and cosmetic surgery; medical therapies; medical services relating to the removal, treatment, processing and storage of human cells and tissue, stem cells and bone marrow, also in the field of regenerative medicine, including tissue engineering; medical services in connection with the removal, treatment, processing and storage of human tissue and stem cells, also in the field of regenerative medicine, including tissue engineering; medical services relating to the cultivation and procurement of stem cells; medical services in connection with the cultivation and procurement of stem cells.;
Receba um e-mail a cada novo despacho publicado na RPI para o processo 501718654 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.
Monitorar esta marca Ver marcas parecidas4 despacho(s) publicado(s) na Revista da Propriedade Industrial.